From: Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells
Parameter
Age (years, mean ± SD*)
57.81 ± 14.11
Sex (M/F)
18/24
Diabetes mellitus
13 (31%)
Diagnosis (eyes)
BRVO
11 (26.2%)
AMD
10 (23.8%)
PDR
7 (16.7%)
CRVO
6 (14.3%)
CSC
5 (11.9%)
DME
3 (7.1%)
Surgical history (eyes)
Cataract surgery